on top of the over $2M investment it made in its IV operations last year. BD (NYSE:BDX) invested $10M to expand production in 2024, which included the addition of new needle and syringe production ...

The BD Medical segment provides peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular access technology, vascular care and preparation ...